[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Page 69132]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27457]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Noramco, Inc.

    By Notice dated August 14, 2013, and published in the Federal 
Register on August 21, 2013, 78 FR 51747, Noramco, Inc., 1440 Olympic 
Drive, Athens, Georgia 30601, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phenylacetone (8501).......................  II
Thebaine (9333)............................  II
Poppy Straw Concentrate (9670).............  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to import Thebaine (9333) analytical standards 
for distribution to its customers. The company plans to import an 
intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol 
for distribution to its customers. The company plans to import the 
Phenylacetone (8501) in bulk for the manufacture of a controlled 
substance.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417(2007).
    In reference to the non-narcotic raw material, any bulk 
manufacturer who is presently, or is applying to be, registered with 
DEA to manufacture such basic classes of controlled substances listed 
in schedules I or II, which fall under the authority of section 
1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in the 
circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 
1316.47.
    DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and 
determined that the registration of Noramco, Inc., to import the basic 
classes of controlled substances is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Noramco, Inc., to ensure that the company's registration 
is consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, 
the above named company is granted registration as an importer of the 
basic classes of controlled substances listed.

    Dated: November 5, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-27457 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P